Basilea Pharmaceutica Ltd.

Swiss Biotech Association

Member

Basilea Pharmaceutica Ltd. (SIX: BSLN) is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. Basilea is committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections.

https://www.basilea.com
+41 61 606 11 11
info@basilea.com
Dr. Peer Nils Schröder

Location

Hegenheimermattweg 167b, 4123 Allschwil, Switzerland

Get Directions

Facts & figures

Type of organization

Public company
Year of foundation

2000
Number of employees in Switzerland

150-249

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Tenpoint Therapeutics GmbH

Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts shaping the regenerative ocular medicine revolution.
4051 Basel

Member

Oncodesign Services

Oncodesign Services is a leading CRO specializing in drug discovery and preclinical services in oncology, inflammation and infectious diseases, through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vitro/in vivo pharmacology.
21000 Dijon

Member

Recolony AG

Recolony focuses on the development of cancer therapies based on microbial-derived products. These drugs have an enormous influence on our immune system, enhancing an immune reaction against cancer. With this approach, Recolony will develop a new class of drugs for the treatment of cancer.
Zürich

Member